Works matching AU Tam, Constantine

Results: 175
    1

    Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era.

    Published in:
    Internal Medicine Journal, 2025, v. 55, n. 7, p. 1105, doi. 10.1111/imj.70050
    By:
    • Barge, Luani;
    • Tran, Steven;
    • Kennedy, Glen;
    • Ritchie, David;
    • Gottlieb, David;
    • Milliken, Sam;
    • Spencer, Andrew;
    • Purtill, Duncan;
    • Perera, Travis;
    • Doocey, Richard;
    • Larsen, Stephen;
    • Butler, Andrew;
    • Bardy, Peter;
    • Greenwood, Matthew;
    • Durrant, Simon;
    • Curley, Cameron;
    • Stewart, Caroline;
    • Tam, Constantine;
    • Balendran, Shalini;
    • Di Ciaccio, Pietro R.
    Publication type:
    Article
    2
    3
    4
    5

    Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.

    Published in:
    2022
    By:
    • Tam, Constantine S.;
    • Gregory, Gareth P.;
    • Ku, Matthew;
    • Fleming, Shaun;
    • Handunnetti, Sasanka M.;
    • Lee, Denise;
    • Walker, Patricia;
    • Perkins, Andrew;
    • Lew, Thomas E.;
    • Sirdesai, Shreerang;
    • Chua, Chong Chyn;
    • Gilbertson, Michael;
    • Lasica, Masa;
    • Anderson, Mary Ann;
    • Renwick, William;
    • Grigg, Andrew;
    • Patil, Sush;
    • Opat, Stephen;
    • Friebe, Adam;
    • Cooke, Rachel
    Publication type:
    Letter to the Editor
    6

    COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

    Published in:
    Internal Medicine Journal, 2021, v. 51, n. 5, p. 763, doi. 10.1111/imj.15247
    By:
    • McCaughan, Georgia;
    • Di Ciaccio, Pietro;
    • Ananda‐Rajah, Michelle;
    • Gilroy, Nicole;
    • MacIntyre, Raina;
    • Teh, Benjamin;
    • Weinkove, Robert;
    • Curnow, Jennifer;
    • Szer, Jeff;
    • Enjeti, Anoop K;
    • Ross, David M;
    • Mulligan, Stephen;
    • Trotman, Judith;
    • Dickinson, Michael;
    • Quach, Hang;
    • Choi, Phillip;
    • Polizzotto, Mark N.;
    • Tam, Constantine S.;
    • Ho, P. Joy;
    • Ku, Matthew
    Publication type:
    Article
    7

    Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic.

    Published in:
    Internal Medicine Journal, 2020, v. 50, n. 6, p. 667, doi. 10.1111/imj.14859
    By:
    • Di Ciaccio, Pietro;
    • McCaughan, Georgia;
    • Trotman, Judith;
    • Ho, Phoebe Joy;
    • Cheah, Chan Y.;
    • Gangatharan, Shane;
    • Wight, Joel;
    • Ku, Matthew;
    • Quach, Hang;
    • Gasiorowski, Robin;
    • Polizzotto, Mark N.;
    • Prince, Henry Miles;
    • Mulligan, Stephen;
    • Tam, Constantine S.;
    • Gregory, Gareth;
    • Hapgood, Greg;
    • Spencer, Andrew;
    • Dickinson, Michael;
    • Latimer, Maya;
    • Johnston, Anna
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 5, p. 1209, doi. 10.1111/bjh.17994
    By:
    • Cull, Gavin;
    • Burger, Jan A.;
    • Opat, Stephen;
    • Gottlieb, David;
    • Verner, Emma;
    • Trotman, Judith;
    • Marlton, Paula;
    • Munoz, Javier;
    • Johnston, Patrick;
    • Simpson, David;
    • Stern, Jennifer C.;
    • Prathikanti, Radha;
    • Wu, Kenneth;
    • Novotny, William;
    • Huang, Jane;
    • Tam, Constantine S.
    Publication type:
    Article
    17

    Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 1, p. 113, doi. 10.1111/bjh.17789
    By:
    • Gould, Clare;
    • Lickiss, Jennifer;
    • Kankanige, Yamuna;
    • Yerneni, Satwica;
    • Lade, Stephen;
    • Gandhi, Maher K.;
    • Chin, Collin;
    • Yannakou, Costas K.;
    • Villa, Diego;
    • Slack, Graham W.;
    • Markham, John F.;
    • Tam, Constantine S.;
    • Nelson, Niles;
    • Seymour, John F.;
    • Dickinson, Michael;
    • Neeson, Paul J.;
    • Westerman, David;
    • Blombery, Piers
    Publication type:
    Article
    18

    Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791
    By:
    • Wierda, William G.;
    • Byrd, John C.;
    • O'Brien, Susan;
    • Coutre, Steven;
    • Barr, Paul M.;
    • Furman, Richard R.;
    • Kipps, Thomas J.;
    • Burger, Jan A.;
    • Stevens, Don A.;
    • Sharman, Jeff;
    • Ghia, Paolo;
    • Flinn, Ian W.;
    • Zhou, Cathy;
    • Ninomoto, Joi;
    • James, Danelle F.;
    • Tam, Constantine S.
    Publication type:
    Article
    19

    Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 504, doi. 10.1111/bjh.15421
    By:
    • Jones, Jeffrey;
    • Mato, Anthony;
    • Coutre, Steven;
    • Byrd, John C.;
    • Furman, Richard R.;
    • Hillmen, Peter;
    • Osterborg, Anders;
    • Tam, Constantine;
    • Stilgenbauer, Stephan;
    • Wierda, William G.;
    • Heerema, Nyla A.;
    • Eckert, Karl;
    • Clow, Fong;
    • Zhou, Cathy;
    • Chu, Alvina D.;
    • James, Danelle F.;
    • O'Brien, Susan M.
    Publication type:
    Article
    20
    21

    The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 1, p. 33, doi. 10.1111/bjh.15018
    By:
    • Jain, Preetesh;
    • Nogueras González, Graciela M.;
    • Kanagal‐Shamanna, Rashmi;
    • Rozovski, Uri;
    • Sarwari, Nawid;
    • Tam, Constantine;
    • Wierda, William G.;
    • Thompson, Philip A.;
    • Jain, Nitin;
    • Luthra, Rajyalakshmi;
    • Quesada, Andres;
    • Sanchez‐Petitto, Gabriela;
    • Ferrajoli, Alessandra;
    • Burger, Jan;
    • Kantarjian, Hagop;
    • Cortes, Jorge;
    • O'Brien, Susan;
    • Keating, Michael J.;
    • Estrov, Zeev
    Publication type:
    Article
    22
    23
    24
    25
    26

    Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 3, p. 462, doi. 10.1111/bjh.14324
    By:
    • Thompson, Philip A.;
    • Lévy, Vincent;
    • Tam, Constantine S.;
    • Al Nawakil, Chadi;
    • Goudot, François‐Xavier;
    • Quinquenel, Anne;
    • Ysebaert, Loic;
    • Michallet, Anne‐Sophie;
    • Dilhuydy, Marie‐Sarah;
    • Van Den Neste, Eric;
    • Dupuis, Jehan;
    • Keating, Michael J.;
    • Meune, Christophe;
    • Cymbalista, Florence
    Publication type:
    Article
    27

    Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 1, p. 77, doi. 10.1111/bjh.14196
    By:
    • Castillo, Jorge J.;
    • Garcia‐Sanz, Ramon;
    • Hatjiharissi, Evdoxia;
    • Kyle, Robert A.;
    • Leleu, Xavier;
    • McMaster, Mary;
    • Merlini, Giampaolo;
    • Minnema, Monique C.;
    • Morra, Enrica;
    • Owen, Roger G.;
    • Poulain, Stephanie;
    • Stone, Marvin J.;
    • Tam, Constantine;
    • Varettoni, Marzia;
    • Dimopoulos, Meletios A.;
    • Treon, Steven P.;
    • Kastritis, Efstathios
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    P1679: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG‐TERM FOLLOW‐UP.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000973588.27391.ea
    By:
    • Tedeschi, Alessandra;
    • Tam, Constantine;
    • Owen, Roger;
    • Buske, Christian;
    • Leblond, Véronique;
    • Dimopoulos, Meletios A.;
    • García‐Sanz, Ramón;
    • Castillo, Jorge;
    • Trotman, Judith;
    • Treon, Steven;
    • Yang, Keri;
    • Tang, Boxiong;
    • Allewelt, Heather;
    • Patel, Sheel;
    • Chan, Wai;
    • Cohen, Aileen;
    • Schneider, Jingjing Yan;
    • Barnes, Gisoo
    Publication type:
    Article
    35
    36
    37

    P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE PHASE 1/2 BRUIN STUDY.

    Published in:
    2023
    By:
    • Scarfò, Lydia;
    • Patel, Manish R.;
    • Eyre, Toby A.;
    • Jurczak, Wojciech;
    • Lewis, David;
    • Gastinne, Thomas;
    • MA, Shuo;
    • Cohen, Jonathon B.;
    • Patel, Krish;
    • Brown, Jennifer R.;
    • Munir, Talha;
    • Lech-Maranda, Ewa;
    • Hoffmann, Marc S.;
    • Ujjani, Chaitra S.;
    • Fakhri, Bita;
    • Wang, Michael;
    • Izutsu, Koji;
    • Nagai, Hirokazu;
    • Tam, Constantine S.;
    • Seymour, John F.
    Publication type:
    Abstract
    38
    39

    P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE.

    Published in:
    2023
    By:
    • Brown, Jennifer R.;
    • Eichhorst, Barbara;
    • Ghia, Paolo;
    • Jurczak, Wojciech;
    • Kahl, Brad;
    • Lamanna, Nicole;
    • Robak, Tadeusz;
    • Shadman, Mazyar;
    • Tam, Constantine;
    • Qiu, Lugui;
    • Cohen, Aileen;
    • Zhang, Meng;
    • Salmi, Tommi;
    • Paik, Jason;
    • Wang, Liping;
    • Zhang, Jun;
    • MA, Han;
    • Tedeschi, Alessandra
    Publication type:
    Abstract
    40
    41

    S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY.

    Published in:
    2023
    By:
    • Brown, Jennifer R.;
    • Desikan, Sai Prasad;
    • Nguyen, Bastien;
    • Won, Helen;
    • Tantawy, Shady;
    • Mcneely, Samuel Clark;
    • Marella, Narasimha;
    • Ebata, Kevin;
    • Woyach, Jennifer;
    • Patel, Krish;
    • Tam, Constantine;
    • Eyre, Toby;
    • Cheah, Chan;
    • Shah, Nirav N;
    • Ghia, Paolo;
    • Jurczak, Wojciech;
    • Balbas, Minna;
    • Nair, Binoj;
    • Abada, Paolo;
    • Wang, Chunxiao
    Publication type:
    Abstract
    42
    43
    44
    45
    46
    47
    48
    49
    50